| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |